Back to list
Medicare's New ACCESS Program Shifts to Outcome-Based Payments to Foster AI Innovation in Healthcare Delivery
Industry NewsMedicareArtificial IntelligenceHealthcare Tech

Medicare's New ACCESS Program Shifts to Outcome-Based Payments to Foster AI Innovation in Healthcare Delivery

The Centers for Medicare & Medicaid Services (CMS) has introduced the ACCESS program, a transformative 10-year initiative designed to test AI-driven medical care at a federal scale. By selecting 150 participants, including the healthcare startup Pair Team, the program aims to move away from traditional fee-for-service models that reimburse based on clinician time. Instead, the ACCESS model rewards measurable health outcomes for chronic conditions such as diabetes, hypertension, and depression. This shift creates a critical financial pathway for AI agents and automated monitoring systems that were previously excluded from federal reimbursement structures. Industry experts suggest this marks a significant move toward creating 'swim lanes' for AI innovation within highly regulated sectors, allowing the most effective technological solutions to succeed based on patient results rather than administrative activity.

Hacker News

Key Takeaways

  • Shift to Outcome-Based Payments: Medicare is moving from reimbursing clinician time to rewarding measurable health outcomes, such as lower blood pressure or reduced pain.
  • The ACCESS Program: A 10-year CMS initiative involving 150 participants designed to test scalable, AI-driven solutions for chronic care management.
  • Financial Pathway for AI: The new model provides a mechanism to pay for AI-driven activities like patient monitoring and care coordination that traditional Medicare does not cover.
  • Focus on Chronic Conditions: The program specifically targets high-impact areas including diabetes, hypertension, chronic kidney disease, obesity, depression, and anxiety.
  • Regulatory Innovation: The initiative creates dedicated 'swim lanes' for AI, allowing the best technological solutions to compete in traditionally rigid healthcare environments.

In-Depth Analysis

Breaking the Time-Based Reimbursement Barrier

For decades, the traditional Medicare reimbursement structure has been a significant hurdle for the integration of artificial intelligence in clinical settings. Under the standard model, payments are primarily tied to the time a clinician spends with a patient. This legacy system lacks a formal mechanism to compensate for the value provided by AI agents that operate between visits. These digital tools—which can monitor patient vitals, conduct automated check-ins, coordinate housing referrals, or ensure medication adherence—do not fit into the 'minutes-per-visit' calculation.

The ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) program addresses this fundamental misalignment. By providing predictable payments for managing qualifying conditions and only awarding the full amount when specific health goals are met, CMS is effectively decoupling healthcare revenue from human labor hours. This transition is essential for AI adoption, as it allows healthcare providers to utilize automated systems to achieve the required health outcomes without losing the financial support that traditionally required a physical or synchronous human presence.

Creating 'Swim Lanes' for AI Innovation

According to Neil Batlivala, CEO of Pair Team—one of the 150 organizations selected for the program—the government is intentionally creating 'swim lanes' for AI innovation. In many regulated industries, the most effective solution does not always win due to bureaucratic hurdles and rigid payment structures. The healthcare sector, in particular, has been slow to adopt cutting-edge technology because the financial incentives were not aligned with technological efficiency.

With the launch of ACCESS on July 5, the federal government is signaling a shift toward a 'best solution wins' philosophy. By focusing on outcomes for chronic diseases like chronic kidney disease and anxiety, the program allows tech-driven companies to prove that AI can manage patient populations more effectively than traditional methods alone. This creates a competitive environment where the efficacy of an AI agent's monitoring or coordination is directly tied to the financial success of the participating healthcare organization.

Industry Impact

The implications of the ACCESS program extend far beyond the 150 initial participants. By establishing a federal-scale testing ground for AI-driven care, CMS is providing a blueprint for how regulated industries can integrate emerging technologies. For the AI industry, this represents the opening of a massive, previously inaccessible market: federal healthcare spending.

If the 10-year program successfully demonstrates that AI-driven care leads to better health outcomes at a lower or more predictable cost, it could lead to a permanent overhaul of how Medicare—and subsequently private insurers—reimburses for medical services. This would likely trigger a surge in investment toward AI healthcare startups that focus on chronic disease management and automated patient navigation, as the 'regulatory moat' that once protected traditional practices begins to transform into a gateway for technological innovation.

Frequently Asked Questions

Question: What is the Medicare ACCESS program?

ACCESS stands for Advancing Chronic Care with Effective, Scalable Solutions. It is a 10-year program launched by the Centers for Medicare & Medicaid Services (CMS) to test a new payment model that rewards health outcomes rather than the volume of clinician activities. It involves 150 participating organizations and is scheduled to go live on July 5.

Question: Why is this payment model better for AI than traditional Medicare?

Traditional Medicare pays based on the time a clinician spends with a patient, which offers no way to pay for AI tools that monitor patients or coordinate care automatically. The ACCESS model pays for results (like lower blood pressure), allowing providers to use AI agents to achieve those results and still receive payment, even if a human clinician isn't involved in every step.

Question: Which medical conditions are covered under the ACCESS program?

The program focuses on managing several chronic conditions, specifically diabetes, hypertension, chronic kidney disease, obesity, depression, and anxiety.

Related News

Japanese Investors Seek $9.4 Billion in Anthropic IPO Shares and Receive $2.98 Billion
Industry News

Japanese Investors Seek $9.4 Billion in Anthropic IPO Shares and Receive $2.98 Billion

Japanese investors sought $9.4 billion in shares in Anthropic’s initial public offering and were ultimately allotted US$2.98 billion, Tech in Asia reported. The report cites a filing for the final allotment. The two figures describe different things: the $9.4 billion is the reported value of the shares Japanese investors sought, while the US$2.98 billion is the value of the shares they were allotted. The allotment was therefore lower than the amount sought. The available report does not identify the investors, explain why the allotment was lower, or give the overall size of the offering. It documents demand and allocation for Japanese investors without establishing how that demand compared with interest from other investors.

Apple Is Hiring to Build an AI Agent That Can Work Across Apps
Industry News

Apple Is Hiring to Build an AI Agent That Can Work Across Apps

Apple is looking for an engineer to lead the creation of its own agentic AI assistant, according to a job listing spotted by Bloomberg and reported by The Verge. The assistant is described as being able to browse the web, work across apps, write code, and call services on a user's behalf. The listing is notable for the range of tasks it names: it describes an assistant that does work for users, rather than establishing how any one capability would function. The available report concerns hiring and the scope of the project. It does not announce a release or say which apps and services the assistant would be able to use.

Meta’s Muse Charm AI Wearable May Cost $300, but Meta Has Not Confirmed the Price
Industry News

Meta’s Muse Charm AI Wearable May Cost $300, but Meta Has Not Confirmed the Price

Meta’s upcoming Muse Charm AI wearable may cost $300, according to a TechCrunch AI article by Lucas Ropek that cites reporting from The Information. Meta did not deny the reporting, saying only that it would “have more to share soon” about the wearable. The distinction is that $300 is a reported possibility, not an official price. Meta’s response indicates that it expects to share more information, but it does not say when that will happen or whether the next update will address pricing. For now, the article establishes that Muse Charm is an upcoming AI wearable and that $300 has been reported as a possible price.